Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia.
Byambajav TO, Bira N, Choijamts G, Davaadorj D, Gantuya B, Sarantuya T, Sarantuya G, Enkhtsetseg A, Erdenetsogt D, Battulga A, Tserentogtokh T, Matsuhisa T, Yamaoka Y, Oyuntsetseg K.
Byambajav TO, et al. Among authors: gantuya b.
Front Pharmacol. 2019 Apr 16;10:394. doi: 10.3389/fphar.2019.00394. eCollection 2019.
Front Pharmacol. 2019.
PMID: 31040783
Free PMC article.